These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Close association of IgA anti-ganglioside antibodies with antecedent Campylobacter jejuni infection in Guillain-Barré and Fisher's syndromes. Koga M, Yuki N, Takahashi M, Saito K, Hirata K. J Neuroimmunol; 1998 Jan; 81(1-2):138-43. PubMed ID: 9521615 [Abstract] [Full Text] [Related]
12. [Clinical utility of measurement for anti-GM1 and anti-GQ1b antibodies]. Tagawa Y, Matsumoto Y, Yuki N. No To Shinkei; 1998 Sep; 50(9):849-53. PubMed ID: 9789308 [Abstract] [Full Text] [Related]
14. [Development of testing kits of anti-ganglioside antibody: clinical utility in Guillain-Barré and Fisher syndromes]. Akiyama M, Koga M, Yoshino H, Hamaoka A, Noguchi Y, Hirata K, Yuki N. No To Shinkei; 2006 Jun; 58(6):477-81. PubMed ID: 16856515 [Abstract] [Full Text] [Related]
15. Association of IgG anti-GD1a antibody with severe Guillain-Barré syndrome. Yuki N, Yamada M, Sato S, Ohama E, Kawase Y, Ikuta F, Miyatake T. Muscle Nerve; 1993 Jun; 16(6):642-7. PubMed ID: 8502262 [Abstract] [Full Text] [Related]
16. Subclass distribution and the secretory component of serum IgA anti-ganglioside antibodies in Guillain-Barré syndrome after Campylobacter jejuni enteritis. Koga M, Yuki N, Hirata K. J Neuroimmunol; 1999 May 03; 96(2):245-50. PubMed ID: 10337924 [Abstract] [Full Text] [Related]
17. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a. Tatsumoto M, Koga M, Gilbert M, Odaka M, Hirata K, Kuwabara S, Yuki N. J Neuroimmunol; 2006 Aug 03; 177(1-2):201-8. PubMed ID: 16844234 [Abstract] [Full Text] [Related]